Johan Jendle - Dissemin

All papers authored by Johan Jendle

This paper was not found in any repository, but could be made available legally by the author.

Johan Jendle

, Maria Ida Buompensiere, Asli Zeynep Ozdemir Saltik, Simona de Portu, Jayne Smith-Palmer

, Richard F. Pollock, Ohad Cohen

A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes

Upload

2022 Kristoffer Nilsson

, Emelie Andersson, Katarina Steen Carlsson

, Sofie Persson

, Kristina Karlsdotter, Josefin Skogsberg, Staffan Gustavsson, Johan Jendle

, Katarina Steen Carlsson

Model‐based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease

Upload

Sofie Persson

, Kristoffer Nilsson, Katarina Steen Carlsson

, Kristina Karlsdotter, Josefin Skogsberg, Staffan Gustavsson, Johan Jendle

, Katarina Steen Carlsson

Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital‐based care, days absent from work, costs and mortality

Upload

Johan Jendle

, Björn Agvall, Alexander Galozy, Peter Adolfsson

Patterns and Predictors Associated With Long-Term Glycemic Control in Pediatric and Young Adult Patients with Type 1 Diabetes

Upload

Johan Jendle

Analysis of “Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States”

Upload

This paper is made freely available by the publisher.

J. Jendle

, M. I. Buompensiere, A. L. Holm, S. de Portu, S. J. P. Malkin, O. Cohen

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden

Download from doi.org

David C. Klonoff

, Jing Wang

, David Rodbard

, Michael A. Kohn

, Chengdong Li

, Dorian Liepmann

, David Kerr

, David Ahn

, Anne L. Peters

, Guillermo E. Umpierrez

, Jane Jeffrie Seley

, Nicole Y. Xu

, Kevin T. Nguyen

, Gregg Simonson

, Michael S. D. Agus

and 79 other authors

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Download from journals.sagepub.com

2021 J. Jendle

, T. Hyötyläinen, M. Orešič, T. Nyström

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

Download from doi.org

2020 Johan Jendle

, Åsa Ericsson, Jens Gundgaard, Jonas Bech Møller, William J. Valentine, Barnaby Hunt

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

Download from doi.org

Emelie Andersson, Sofie Persson

, Nino Hallén, Åsa Ericsson, Desirée Thielke, Peter Lindgren

, Katarina Steen Carlsson, Katarina Steen Carlsson

, Johan Jendle

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

Upload

Distributing this paper is prohibited by the publisher

Johan Jendle

, Åsa Ericsson, Bertil Ekman

, Stefan Sjöberg, Jens Gundgaard, João da Rocha Fernandes, Ann-Charlotte Mårdby

, Barnaby Hunt

, Samuel Jp P. Malkin

, Maria Thunander

Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective

Upload

Johan Jendle

The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic

Upload

2019 Johan Jendle

, Andreas L. Birkenfeld, William H. Polonsky, Robert Silver, Kari Uusinarkaus, Thomas Hansen, Jonas Håkan‐Bloch, Sayeh Tadayon, Melanie J. Davies

Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials

Upload

2018 Johan Jendle

, Xin Fang, Yang Cao, Leif Bojö, Bo K. Nilsson, Fredric Hedberg, Irene Santos-Pardo, Thomas Nyström

Effects on repetitive 24-hour ambulatory blood pressure in subjects with type II diabetes randomized to liraglutide or glimepiride treatment both in combination with metformin: a randomized open parallel-group study

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2016 J. Jendle

, G. Grunberger, T. Blevins, F. Giorgino, Hietpas Rt, Botros Ft

Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program.

Upload

Martin Ridderstråle, Lyndon Marc Evans, Henrik Holm Jensen, Mette Bøgelund, Marie Markert Jensen, Åsa Ericsson, Johan Jendle

Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study

Download from dx.doi.org

2015 M. Evans, M. Ridderstråle, Jensen Hh, M. Bøgelund, Mm Jensen, Å. Ericsson, J. Jendle

Quantifying The Short-Term Impact of Changes In Hba1c, Weight And Insulin Regimen on Health Related Quality-of-Life

Download from doi.org

This paper is available in a repository.

Peter Adolfsson

, Stig Mattsson, Johan Jendle

Evaluation of glucose control when a new strategy of increased carbohydrate supply is implemented during prolonged physical exercise in type 1 diabetes

Download from www.researchgate.net

Isabelle Steineck, Jan Cederholm, Bj Eliasson, Araz Rawshani, Katarina Eeg-Olofsson, Ann-Marie Svensson, Bj Zethelius, Tarik Avdic, Mona Landin-Olsson, Johan Jendle

, Soffia Gudbjörnsdóttir

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study

Download from dx.doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Johan Jendle